Health-related quality of life (HRQOL) results from PRESTO (AFT-19), a phase 3 randomized trial of intensification of androgen blockade in patients with high-risk biochemically relapsed castration sensitive prostate cancer Meeting Abstract
| Authors: | Chen, R. C.; Mazza, G. L.; Fruth, B.; Xiao, H.; Picus, J.; Taplin, M. E.; Dorff, T. B.; Appleman, L. J.; Weckstein, D. J.; Patnaik, A.; Bryce, A. H.; Shevrin, D.; Mohler, J. L.; Anderson, D. M.; Rao, A.; Tan, A.; Ryan, C. J.; Eggener, S.; Morris, M. J.; Aggarwal, R. R. |
| Abstract Title: | Health-related quality of life (HRQOL) results from PRESTO (AFT-19), a phase 3 randomized trial of intensification of androgen blockade in patients with high-risk biochemically relapsed castration sensitive prostate cancer |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557401253 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.5006 |
| Notes: | Meeting Abstract: 5006 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
